Apolipoprotein E alters metabolism of AβPP in cells engaged in β- amyloidosis

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 3, 1999, Pages 288-295

  Mazur Kolecka, Bozena ^a   Frackowiak, Janusz ^a   Krzeslowska, Jolanta ^a   Ramakrishna, Narayan ^a   Haske, Taraneh ^b   Emmerling, Mark R ^b   Zhang, Wei ^a   Kim, Kwang S ^a   Wisniewski, Henryk M ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b PFIZER INC   (United States)

Author keywords

Apolipoprotein E isoforms; A accumulation; A PP; Smooth muscle cell culture

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; MESSENGER RNA;

AMYLOIDOSIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOG; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SMOOTH MUSCLE FIBER;

EID: 0033031485     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199903000-00008     Document Type: Article

References (43)

1. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-31
2. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30
3. Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E ∈2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-21
4. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein polymorphism and Alzheimer's disease. Lancet 1993;342:697-99
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele etha4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72
6. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-81
7. Amouyel P, Vidal O, Launay JM, et al. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994;344:1315-18
8. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Arteriosclerosis 1983;3:310-15
9. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-66
10. Wisniewski T, Frangione B, Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-38
11. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid deposition as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90: 9649-53
12. Lehtovirta M, Laakso MP, Soininen H., et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995;67:65-72
13. Honer WG, Dickson DW, Gleeson J, et al. Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 1992;13:375-82
14. Naslund J, Thyberg J, Tjernberg LO, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 1995;15:219-28
15. LaDu MJ, Falduto MT, Manelli AM, et al. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23403-6
16. Ma J, Yee A, Brewer HB, et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-94
17. Wisniewski T, Castano EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-35
18. Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 1994;264:850-52
19. Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4, cholinergic integrity, synapticity and Alzheimer's disease. In: Roses AD, et al, eds. Apolipoprotein E and Alzheimer's disease. Springer-Verlag Berlin Heidelberg, 1996:20-26
20. Perry EK, Gibson PH, Blessed G. Neurotransmitter enzyme abnormalities in senile dementia. J Neurol Sci 1977;34:247-65
21. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 1994;53:637-45
22. Wisniewski HM, Frackowiak J, Zoltowska A, et al. Vascular β-amyloid in Alzheimer disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid Int J Clin Exp Invest 1994;1:8-16
23. Wegiel J, Wisniewski H, Dziewiatkowski J, et al. The origin of amyloid in cerebral vessels of aged dogs. Brain Res 1995;705:225-34
24. Wisniewski HM, Frackowiak J, Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 1995;183:120-23
25. Frackowiak J, Mazur-Kolecka B, Wisniewski HM, et al. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res 1995;676: 225-30
26. Frackowiak J, Mazur-Kolecka B, Wegiel J, et al. Culture of canine vascular myocytes as a model to study production and accumulation of β-protein by cells involved in amyloidogenesis. In Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds. Research advances in Alzheimer's disease and related Disorders. John Wiley & Sons Ltd: Chichester, 1995:747-54
27. Mazur-Kolecka B, Frackowiak J, Wisniewski HM. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells. Brain Res 1995;698:217-22
28. Mazur-Kolecka B, Frackowiak J, Carroll RT, et al. Accumulation of Alzheimer's amyloid-β-peptide in cultured myocytes is enhanced by serum and reduced by cerebrospinal fluid. J Neuropathol Exp Neurol 1997;56:263-72
29. Caporaso GL, Gandy SE, Buxbaum JD, et al. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid protein. Proc Natl Acad Sci USA 1992;89:2252-56
30. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-59
31. Ramakrishna N, Smedman M, Gillam B. Suppression of Alzheimer amyloid precursor protein expression by exogenous APP mRNA. Arch Bioch Biophys 1996;326:243-51
32. Majack RA, Castle CK, Goodman LV, et al. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol 1988;107:1207-13
33. Brzoxowska A, Fries R, Womack JE, et al. Isolation, sequencing and expression analysis of a bovine apolipoprotein E (APOE) c DNA and chromosomal localization of the APOE locus. Mamm Genome 1993;4:53-57
34. Luo C-C, Li W-H, Chan L. Structure and expression of dog apolipoprotein A-I, E. and C-I mRNAs: Implications for the evolution and functional constraints of apolipoprotein structure. J Lipid Res 1989;30:1735-46
35. Kounnas MZ, Moir RD, Rebeck GW, et al. LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 1995;82:331-40
36. Arribas J, Massague J. Transforming growth factor-α and β-amyloid precursor protein share a secretory mechanism. J Cell Biol 1995;128:433-41
37. Davis-Salinas J, Saporito-Irwin SM, Cotman CW, et al. Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 1995;65:931-34
38. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-37
39. Herz J, Kowal RC, Ho YK, et al. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver. J Biol Chem 1990;265:21355-62
40. Takahashi S, Kawarabayashi Y, Nakai T, et al. Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 1992;89:9252-56
41. Scharnagl H, Winkler K, Huttinger M, et al. The βA4 amyloid peptide enhances cellular uptake of apolipoprotein E-containing lipoproteins by the low-density lipoprotein receptor-related protein/alpha2-macroglobulin receptor. In: Roses AD, et al, eds. Apolipoprotein E and Alzheimer's disease. Springer-Verlag: Berlin Heidelberg, 1996:136-44
42. Tienari PJ, Ida N, Ikonen E, et al. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA 1997;94: 4125-30
43. Maggio JE, Stimson ER, Ghilard JR, et al. Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labelled amyloid peptide. Proc Natl Acad Sci USA 1994;89:5462-66